CoreAge Rx vs Alan Meds
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Alan Meds head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 77 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Alan Meds a bad call — it's best for readers comparing prepaid and flexible treatment options who can confirm the full payment, state access and processing dates before enrolling. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Alan Meds |
|---|---|---|
| Brief Score | 94/100 (A) | 77/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm full prepaid charge Advertised $158/mo equivalent on two months paid upfront; full selected total and renewal need confirmation. Full price detailsCompounded semaglutide offered. Current medication quote unknown; earlier observed from $158/month for compounded semaglutide |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm full prepaid charge Advertised $325/mo equivalent on six months paid upfront; full selected total and renewal need confirmation. Full price detailsCompounded tirzepatide offered. Current medication quote unknown; earlier observed from $295/month for compounded tirzepatide |
| Coverage | US only; restrictions by state, confirmed at intake | Compounded semaglutide: 46 states and D.C.; excludes Alaska, Hawaii, Louisiana and Mississippi. Other programs require confirmation |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Alan Meds: Current full quotes require confirmation. The public semaglutide offer is a prepaid two-month promotion; the tirzepatide equivalent requires six months upfront. Earlier prices remain historical.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.